Kathleen Goin reports large share dispositions at Palvella (NASDAQ: PVLA)

Rhea-AI Filing Summary

Palvella Therapeutics submitted an amended Form 144/A reporting multiple dispositions of Common Stock by Kathleen Goin. The filing lists sales of 370,965 shares on 11/19/2025, 415,022 shares on 12/17/2025, and 419,983 shares on 01/21/2026. The notice also shows a planned transaction dated 02/18/2026 described as a Stock Option Exercise with cash proceeds and identifies Piper Sandler & Co. as the broker.

Insights

Securities Compliance Analyst

Form 144/A lists multiple insider dispositions and a scheduled option exercise.

The filing records three separate reported dispositions by Kathleen Goin: 370,965 shares on 11/19/2025, 415,022 shares on 12/17/2025, and 419,983 shares on 01/21/2026. These entries are typical regulatory notices required when certain sale thresholds or conditions are met.

The excerpt also shows a planned Stock Option Exercise on 02/18/2026 with cash noted as the method of payment and Piper Sandler & Co. listed as broker. Cash‑flow treatment and any resulting share counts after the exercise are timing/details not included in the provided excerpt.

Equity Markets Specialist

Large, discrete insider sales are reported across three months; market impact depends on context not shown here.

The listed sales — 370,965, 415,022, and 419,983 shares — are material in scale by raw share counts but the filing excerpt does not state total outstanding shares or current float to assess dilution or market pressure.

Subsequent filings or public disclosures may provide aggregate ownership or post‑transaction positions; absent those figures, assessment of investor impact requires additional context.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144/A

144/A: Filer Information

Filer CIK
Filer CCC
Previous Accession Number Of The Filing
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144/A: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144/A: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Piper Sandler & Co Inc 350 North 5th Street Minneapolis MN 55401	4302	344547.00	11836490	02/18/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144/A: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/18/2026	Stock Option Exercise	Issuer			4302	02/18/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144/A: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Kathleen Goin C/O Palvella Therapeutics Inc 353 W Lancaster Ave Wayne PA 19087	Common Stock	11/19/2025	4302	370965.00
Kathleen Goin C/O Palvella Therapeutics Inc 353 W Lancaster Ave Wayne PA 19087	Common Stock	12/17/2025	4302	415022.00
Kathleen Goin C/O Palvella Therapeutics Inc 353 W Lancaster Ave Wayne PA 19087	Common Stock	01/21/2026	4302	419983.00

144/A: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does PVLA's Form 144/A report?

The filing reports multiple dispositions of Common Stock by Kathleen Goin on 11/19/2025, 12/17/2025, and 01/21/2026. It also lists a planned Stock Option Exercise dated 02/18/2026.

How many PVLA shares did Kathleen Goin sell in the filings?

The excerpt lists sales of 370,965, 415,022, and 419,983 shares on the three reported dates. These are the specific per‑transaction share counts shown in the filing excerpt.

Does the Form 144/A show who handled the transactions for PVLA?

Yes. The filing names Piper Sandler & Co. with an address in Minneapolis as the broker referenced in the securities information section of the excerpt.

Was the 02/18/2026 transaction an open‑market sale or exercise?

The excerpt describes the 02/18/2026 entry as a Stock Option Exercise with Cash indicated as the method; it is identified as an issuer‑related exercise in the provided lines.

Do these Form 144/A entries state how many shares remain owned?

The provided excerpt does not include a post‑transaction beneficial ownership total or shares outstanding figure. The lines only list specific dispositions and the planned exercise dates.